Panacea Biotec reports consolidated net loss of Rs 54.14 crore in the March 2021 quarter

Sales rise 34.23% to Rs 168.27 crore

Net Loss of Panacea Biotec reported to Rs 54.14 crore in the quarter ended March 2021 as against net loss of Rs 69.70 crore during the previous quarter ended March 2020. Sales rose 34.23% to Rs 168.27 crore in the quarter ended March 2021 as against Rs 125.36 crore during the previous quarter ended March 2020.

For the full year,net loss reported to Rs 147.65 crore in the year ended March 2021 as against net loss of Rs 194.29 crore during the previous year ended March 2020. Sales rose 14.84% to Rs 624.81 crore in the year ended March 2021 as against Rs 544.06 crore during the previous year ended March 2020.

 

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales168.27125.36 34 624.81544.06 15 OPM %0.56-19.29 -12.034.58 - PBDT-41.07-50.50 19 -100.09-119.03 16 PBT-52.65-60.55 13 -145.69-162.25 10 NP-54.14-69.70 22 -147.65-194.29 24

Powered by Capital Market - Live News